相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predictive inflammatory biomarkers for change in suicidal ideation in major depressive disorder and panic disorder: A 12-week follow-up study
Kwan Woo Choi et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2021)
Effects of infliximab on brain neurochemistry of adults with bipolar depression
Rodrigo B. Mansur et al.
JOURNAL OF AFFECTIVE DISORDERS (2021)
The real world impact of adalimumab on quality of life and the physical and psychological effects of moderate-to-severe psoriasis: a UK prospective, multicenter, observational study
Joyce Leman et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2020)
Efficacy of infliximab in treatment-resistant depression: A systematic review and meta-analysis
Daniela Bavaresco et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
TNF-α and its soluble receptors mediate the relationship between prior severe mood episodes and cognitive dysfunction in euthymic bipolar disorder
C. E. Millett et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I/II depression
Yena Lee et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Systemic TNF-α blockade attenuates anxiety and depressive-like behaviors in db/db mice through downregulation of inflammatory signaling in peripheral immune cells
Musaad A. Alshammari et al.
SAUDI PHARMACEUTICAL JOURNAL (2020)
Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression
Rodrigo B. Mansur et al.
CELLS (2020)
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy
Roberta Roberti et al.
CURRENT MEDICAL RESEARCH AND OPINION (2020)
Suicidal Risks in 12 DSM-5 Psychiatric Disorders
R. J. Baldessarini et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression
Rodrigo B. Mansur et al.
PSYCHONEUROENDOCRINOLOGY (2020)
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study
Luigi Francesco Iannone et al.
PLOS ONE (2020)
Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)
Casper Webers et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Depression in the Primary Care Setting
Lawrence T. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Etanercept reduces anxiety and depression in psoriasis patients, and sustained depression correlates with reduced therapeutic response to etanercept
A. Yang et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2019)
Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial
Roger S. McIntyre et al.
JAMA PSYCHIATRY (2019)
Biomarker-Guided Anti-inflammatory Therapies: From Promise to Reality Check
Michael Berk et al.
JAMA PSYCHIATRY (2019)
Depression Symptoms Predict Worse Clinical Response to Etanercept Treatment in Psoriasis Patients
Waishu Jin et al.
DERMATOLOGY (2019)
Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions
N. Kappelmann et al.
MOLECULAR PSYCHIATRY (2018)
Decreased Resting-State Interhemispheric Functional Connectivity Correlated with Neurocognitive Deficits in Drug-Naive First-Episode Adolescent-Onset Schizophrenia
Yi Liu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Out-of-pocket health expenditures in patients with bipolar disorder, anxiety, schizophrenia and other psychotic disorders: findings from a study in a psychiatry outpatient clinic in Turkey
Duygu Islek et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2018)
Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities
Madeline L. Pfau et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)
TNFα, disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice
Yuyan Cheng et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Molecular mechanisms of action of anti-TNF-alpha agents - Comparison among therapeutic TNF-alpha antagonists
Hiroki Mitoma et al.
CYTOKINE (2018)
Anxiety and depression in patients with moderate-to-severe psoriasis and comparison of change from baseline after treatment with guselkumab vs. adalimumab: results from the Phase 3 VOYAGE 2 study
K. B. Gordon et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Peripheral Etanercept Administration Normalizes Behavior, Hippocampal Neurogenesis, and Hippocampal Reelin and GABAA Receptor Expression in a Preclinical Model of Depression
Kyle J. Brymer et al.
FRONTIERS IN PHARMACOLOGY (2018)
Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants
David Martin-Hernandez et al.
JOURNAL OF NEUROINFLAMMATION (2018)
The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
Sahar Mohamed El-Haggar et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2018)
Valproic Acid and Lithium Meditate Anti-Inflammatory Effects by Differentially Modulating Dendritic Cell Differentiation and Function
Sy-Jye Leu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial
Muhammad Husain et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy
Paula Kopschina Feltes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Blood-Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer's Disease
Rudy Chang et al.
MOLECULAR PHARMACEUTICS (2017)
Social stress induces neurovascular pathology promoting depression
Caroline Menard et al.
NATURE NEUROSCIENCE (2017)
Efficacy of cognitive-behavioral therapy in patients with bipolar disorder: A meta-analysis of randomized controlled trials
Kai-Jo Chiang et al.
PLOS ONE (2017)
Chronic administration of fluoxetine and pro-inflammatory cytokine change in a rat model of depression
Yanxia Lu et al.
PLOS ONE (2017)
Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies
C. A. Kohler et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Effects of olanzapine on LPS-induced inflammation in rat primary glia cells
Caroline Faour-Nmarne et al.
INNATE IMMUNITY (2016)
TNF biology, pathogenic mechanisms and emerging therapeutic strategies
George D. Kalliolias et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013
Alize J. Ferrari et al.
BIPOLAR DISORDERS (2016)
The Kynurenine and Melatonergic Pathways in Psychiatric and CNS Disorders
George Anderson
CURRENT PHARMACEUTICAL DESIGN (2016)
Infliximab ameliorating depression-like behavior through inhibiting the activation of the IDO-HAAO pathway mediated by tumor necrosis factor-α in a rat model
Xiao-Yan Fu et al.
NEUROREPORT (2016)
Psychotropic drugs attenuate lipopolysaccharide-induced hypothermia by altering hypothalamic levels of inflammatory mediators in rats
Ahmad Nassar et al.
NEUROSCIENCE LETTERS (2016)
Treatment-Resistant Bipolar Depression: A Randomized Controlled Trial of Electroconvulsive Therapy Versus Algorithm-Based Pharmacological Treatment
Helle K. Schoeyen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Celecoxib adjunctive therapy for acute bipolarmania: a randomized, double-blind, placebo-controlled trial
Somayeh Arabzadeh et al.
BIPOLAR DISORDERS (2015)
Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment
Anniella Isgren et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Neuroinflammatory TNFα Impairs Memory via Astrocyte Signaling
Samia Habbas et al.
CELL (2015)
IL-23 and TGF-β1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode
Haozhe Li et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Dysregulation of the NF-κB pathway as a potential inducer of bipolar disorder
Eran Elhaik et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data
Brian Shine et al.
LANCET (2015)
TNF AND ITS RECEPTORS IN THE CNS: THE ESSENTIAL, THE DESIRABLE AND THE DELETERIOUS EFFECTS
L. Probert
NEUROSCIENCE (2015)
THE ROLE OF INFLAMMATION AND MICROGLIAL ACTIVATION IN THE PATHOPHYSIOLOGY OF PSYCHIATRIC DISORDERS
G. Z. Reus et al.
NEUROSCIENCE (2015)
The effect of the antipsychotic drug quetiapine and its metabolite norquetiapine on acute inflammation, memory and anhedonia
Emily J. Jaehne et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
Mortality in Mental Disorders and Global Disease Burden Implications A Systematic Review and Meta-analysis
Elizabeth Reisinger Walker et al.
JAMA PSYCHIATRY (2015)
Effects of Risperidone on Cytokine Profile in Drug-Naive First-Episode Psychosis
Cristiano Noto et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Lithium nephrotoxicity
Abed N. Azab et al.
INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS (2015)
Effects of Lithium on Inflammation
Ahmad Nassar et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro
Anitta K. Sarvari et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future
Lisa M. Sedger et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
Open-Label Observation of Addition of Etanercept Versus a Conventional Disease-Modifying Antirheumatic Drug in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy in the Latin American Region
Daniel A. Machado et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2014)
Lipopolysaccharide repeated challenge followed by chronic mild stress protocol introduces a combined model of depression in rats: Reversibility by imipramine and pentoxifylline
Al-Shaimaa A. Elgarf et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
NF-κB Mediated Regulation of Adult Hippocampal Neurogenesis: Relevance to Mood Disorders and Antidepressant Activity
Valeria Bortolotto et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Chronic Administration of Infliximab (TNF-α Inhibitor) Decreases Depression and Anxiety-like Behaviour in Rat Model of Chronic Mild Stress
Ayse Karson et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2013)
Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies
Amirhossein Modabbernia et al.
BIOLOGICAL PSYCHIATRY (2013)
Improved health outcomes with Etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis
Sang-Cheol Bae et al.
BMC MUSCULOSKELETAL DISORDERS (2013)
Microglia and neurodegeneration: The role of systemic inflammation
Colm Cunningham
GLIA (2013)
TNF-α signalling and inflammation: interactions between old acquaintances
Hana Zelova et al.
INFLAMMATION RESEARCH (2013)
Antidepressant effects of TNF-α blockade in an animal model of depression
Ute Kruegel et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis
Klaus Munkholm et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions
Tina Bhutani et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Patient-reported outcomes in moderate-to-severe plaque psoriasis with scalp involvement: results from a randomized, double-blind, placebo-controlled study of etanercept
S. Tyring et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
Harvey A. Whiteford et al.
LANCET (2013)
The Pro-inflammatory Cytokine TNF-α Regulates the Activity and Expression of the Serotonin Transporter (SERT) in Astrocytes
Sandra Malynn et al.
NEUROCHEMICAL RESEARCH (2013)
Depression after myocardial infarction: TNF-α-induced alterations of the blood-brain barrier and its putative therapeutic implications
Hui Liu et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Effects of long-term etanercept treatment on anxiety- and depression-like neurobehaviors in rats
Dilek Bayramgurler et al.
PHYSIOLOGY & BEHAVIOR (2013)
The Epidemiological Modelling of Major Depressive Disorder: Application for the Global Burden of Disease Study 2010
Alize J. Ferrari et al.
PLOS ONE (2013)
Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis
Valerie Tourjman et al.
SCHIZOPHRENIA RESEARCH (2013)
Effects of pentoxifylline, 7-nitroindazole, and imipramine on tumor necrosis factor-alpha and indoleamine 2,3-dioxygenase enzyme activity in the hippocampus and frontal cortex of chronic mild-stress-exposed rats
Bassim Msa Mohamed et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2013)
Comorbidities and Mortality in Bipolar Disorder A Swedish National Cohort Study
Casey Crump et al.
JAMA PSYCHIATRY (2013)
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
Charles L. Raison et al.
JAMA PSYCHIATRY (2013)
Celecoxib or Naproxen Treatment Does Not Benefit Depressive Symptoms in Persons Age 70 and Older: Findings From a Randomized Controlled Trial
Cynthia Fields et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2012)
Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells
Sigalit Nahman et al.
INNATE IMMUNITY (2012)
Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study
Seyed-Hesameddin Abbasi et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression
Yang Liu et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
The Epidemiology of Depression and the Evolution of Treatment
Robert M. A. Hirschfeld
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Tumor Necrosis Factor-alpha and the Roles it Plays in Homeostatic and Degenerative Processes Within the Central Nervous System
Sara L. Montgomery et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens
R. Gniadecki et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial
Liliana Gonzalez-Espinoza et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level
I. Ertenli et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities Subanalysis of Results from a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
Alexa B. Kimball et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2011)
Pretreatment with pentoxifylline has antidepressant-like effects in a rat model of acute myocardial infarction
Thierno Madjou Bah et al.
BEHAVIOURAL PHARMACOLOGY (2011)
Pentoxifylline attenuates TNF-α protein levels and brain edema following temporary focal cerebral ischemia in rats
Abedin Vakili et al.
BRAIN RESEARCH (2011)
The use of pentoxifylline as adjuvant therapy with praziquantel downregulates profibrogenic cytokines, collagen deposition and oxidative stress in experimental schistosomiasis mansoni
Naglaa El-Lakkany et al.
EXPERIMENTAL PARASITOLOGY (2011)
β-Adrenergic Receptor Antagonism Prevents Anxiety-Like Behavior and Microglial Reactivity Induced by Repeated Social Defeat
Eric S. Wohleb et al.
JOURNAL OF NEUROSCIENCE (2011)
Peripheral biomarkers and illness activity in bipolar disorder
Flavio Kapczinski et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2011)
Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia
Sigrun Hope et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2011)
Elevation of cerebrospinal fluid interleukin-1β in bipolar disorder
Johan Soderlund et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2011)
Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients
H-W Kim et al.
MOLECULAR PSYCHIATRY (2011)
Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression
R. C. Shelton et al.
MOLECULAR PSYCHIATRY (2011)
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
Jonas Hannestad et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Astrocytic-neuronal crosstalk: Implications for neuroprotection from brain injury
George E. Barreto et al.
NEUROSCIENCE RESEARCH (2011)
Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial
J. Kekow et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein
Ruben J. Boado et al.
JOURNAL OF BIOTECHNOLOGY (2010)
Inflammatory Biomarkers in 70 Depressed Inpatients With and Without the Metabolic Syndrome
Sara Zeugmann et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression
Breno Satler Diniz et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: A randomized clinical trial
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients
J. S. Rao et al.
MOLECULAR PSYCHIATRY (2010)
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression
C. L. Raison et al.
MOLECULAR PSYCHIATRY (2010)
Inflammatory Markers in Schizophrenia: Comparing Antipsychotic Effects in Phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness Study
Jonathan M. Meyer et al.
BIOLOGICAL PSYCHIATRY (2009)
Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder
Marcia Kauer-Sant'Anna et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder: A Systematic Review of the Literature
Benjamin I. Goldstein et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression
Firdaus S. Dhabhar et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2009)
Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study
E. Dauden et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
NEUROSCIENCE Glia - more than just brain glue
Nicola J. Allen et al.
NATURE (2009)
Medical Evaluation of Patients Undergoing Electroconvulsive Therapy
Anjala V. Tess et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice
Haruhiko Sugino et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Pro-inflammatory biomakers in depression: Treatment with venlafaxine
John E. Piletz et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2009)
Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trial
Binay Krishna De et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Effects of Adalimumab Maintenance Therapy on Health-Related Quality of Life of Patients With Crohn's Disease: Patient-Reported Outcomes of the CHARM Trial
Edward V. Loftus et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease - A randomized placebo-controlled study
Juliano Lara Fernandes et al.
ATHEROSCLEROSIS (2008)
Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study
Fabiano G. Nery et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?
J. S. Rao et al.
MOLECULAR PSYCHIATRY (2008)
Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants
Jaegyu Hwang et al.
NEUROPHARMACOLOGY (2008)
Mechanisms of disease: Major depressive disorder
R. H. Belmaker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Daniel Tracey et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Increased plasma levels of 8-iso-PGF2α and IL-6 in an elderly population with depression
Nikolaos Dimopoulos et al.
PSYCHIATRY RESEARCH (2008)
Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: Continuous versus interrupted treatment
Joel M. Gelfand et al.
VALUE IN HEALTH (2008)
Chronic administration of lamotrigine downregulates COX-2 mRNA and protein in rat frontal cortex
Ho-Joo Lee et al.
NEUROCHEMICAL RESEARCH (2008)
Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks
R. Krishnan et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Electroconvulsive therapy for depression
Sarah H. Lisanby
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effects of pentoxifylline on TNF-α production by peripheral blood mononuclear cells in patients with nonalcoholic steatohepatitis
Deniz G. Duman et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Cutting edge:: TNF-α-cinverting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock
Keisuke Horiuchi et al.
JOURNAL OF IMMUNOLOGY (2007)
Chronic treatment of rats with sodium valproate downregulates frontal cortex NF-κB DNA binding activity and COX-2 mRNA
Jagadeesh S. Rao et al.
BIPOLAR DISORDERS (2007)
Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder
Faith Dickerson et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Crohn's disease, fatigue, and infliximab: Is there a role for cytokines in the pathogenesis of fatigue?
Itta M. Minderhoud et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Adherence to antidepressant treatment among privately insured patients diagnosed with depression
Ayse Akincigil et al.
MEDICAL CARE (2007)
Effects of estrogen against LPS-induced inflammation and toxicity in primary rat glial and neuronal cultures
Meytal Tenenbaum et al.
JOURNAL OF ENDOTOXIN RESEARCH (2007)
Tumor necrosis factor antagonists: Different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection
Daniel E. Furst et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2006)
The proinflammatory cytokines interleukin-1 beta and tumor necrosis factor-alpha activate serotonin transporters
Chong-Bin Zhu et al.
NEUROPSYCHOPHARMACOLOGY (2006)
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression:: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
N Müller et al.
MOLECULAR PSYCHIATRY (2006)
Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: Relevance to bipolar disorder
RP Bazinet et al.
BIOLOGICAL PSYCHIATRY (2006)
Cytokine profiles in bipolar affective disorder: Focus on acutely ill patients
SM O'Brien et al.
JOURNAL OF AFFECTIVE DISORDERS (2006)
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial
S Tyring et al.
LANCET (2006)
Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: Impact of past episodes
HA Savas et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2006)
Astrocytes, from brain glue to communication elements: The revolution continues
A Volterra et al.
NATURE REVIEWS NEUROSCIENCE (2005)
The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab
P Persoons et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
ML Block et al.
PROGRESS IN NEUROBIOLOGY (2005)
β-Amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor α and NMDA receptors
AM Floden et al.
JOURNAL OF NEUROSCIENCE (2005)
Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline - Results of a randomized study
K Sliwa et al.
CIRCULATION (2004)
Hypertonic stress activates glycogen synthase kinase 3β-mediated apoptosis of renal medullary interstitial cells, suppressing an NFκB-driven cyclooxygenase-2-dependent survival pathway
R Rao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Medical progress: Bipolar disorder
RH Belmaker
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Immunologic variables in acute mania of bipolar disorder
HC Liu et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy
K Sliwa et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Effects of antidepressants on cytokine production and actions
N Castanon et al.
BRAIN BEHAVIOR AND IMMUNITY (2002)
Binding and functional comparisons of two types of tumor necrosis factor antagonists
B Scallon et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Revised prevalence estimates of mental disorders in the United States - Using a clinical significance criterion to reconcile 2 surveys' estimates
WE Narrow et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Drug therapy - Medical treatment of peripheral arterial disease and claudication.
WR Hiatt
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids:: a possible common effect of mood stabilizers
MCJ Chang et al.
JOURNAL OF NEUROCHEMISTRY (2001)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)
Affective disorders and suicide risk: A reexamination
JM Bostwick et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: A double-blind, placebo-controlled study
C DeBattista et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Psychosocial disability during the long-term course of unipolar major depressive disorder
LL Judd et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Sodium valproate inhibits production of TNF-α and IL-6 and activation of NF-κB
T Ichiyama et al.
BRAIN RESEARCH (2000)
分享论文
